We are live on ! Find out more
JG

Joel Greenblatt Gotham Asset Management

AUM $43B
1-Year Est. Return 34.97%
 

Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.

This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+34.97%
3 Year Est. Return
+97.97%
5 Year Est. Return
+117.45%
10 Year Est. Return
+441.95%
AUM
$5.39B
AUM Growth
+$549M
Cap. Flow
+$58.4M
Cap. Flow %
1.08%
Top 10 Hldgs %
24.05%
Holding
1,470
New
157
Increased
492
Reduced
650
Closed
145

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$14M
2
LRCX icon
Lam Research
LRCX
+$12.7M
3
META icon
Meta Platforms (Facebook)
META
+$9.54M
4
VMW
VMware, Inc
VMW
+$9.3M
5
VVV icon
Valvoline
VVV
+$9.03M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Industrials 12.68%
3 Consumer Discretionary 10.55%
4 Healthcare 8.73%
5 Financials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COO icon
1351
Cooper Companies
COO
$14.9B
-5,156
Closed -$410K
CRCT icon
1352
Cricut
CRCT
$1.17B
-13,972
Closed -$130K
DLTR icon
1353
Dollar Tree
DLTR
$25.3B
-12,596
Closed -$1.34M
DNLI icon
1354
Denali Therapeutics
DNLI
$3.98B
-19,391
Closed -$400K
ED icon
1355
Consolidated Edison
ED
$39.3B
-72,107
Closed -$6.17M
EFA icon
1356
iShares MSCI EAFE ETF
EFA
$80B
-13,502
Closed -$931K
EHAB
1357
DELISTED
Enhabit
EHAB
-16,700
Closed -$188K
EHC icon
1358
Encompass Health
EHC
$11.9B
-3,201
Closed -$215K
ENB icon
1359
Enbridge
ENB
$110B
-32,381
Closed -$1.07M
ENOV icon
1360
Enovis
ENOV
$1.5B
-14,867
Closed -$784K
ESNT icon
1361
Essent Group
ESNT
$6.12B
-4,935
Closed -$233K
ETD icon
1362
Ethan Allen Interiors
ETD
$595M
-11,239
Closed -$336K
EVLV icon
1363
Evolv Technologies
EVLV
$967M
-17,824
Closed -$86.6K
FA icon
1364
First Advantage
FA
$3.59B
-11,624
Closed -$160K
FIVE icon
1365
Five Below
FIVE
$13.8B
-6,997
Closed -$1.13M
FIZZ icon
1366
National Beverage
FIZZ
$3.03B
-8,852
Closed -$416K
FNV icon
1367
Franco-Nevada
FNV
$51.3B
-3,220
Closed -$430K
FOLD
1368
DELISTED
Amicus Therapeutics
FOLD
-10,606
Closed -$129K
GBX icon
1369
The Greenbrier Companies
GBX
$1.42B
-7,361
Closed -$294K
TDAY
1370
USA Today Co
TDAY
$950M
-12,614
Closed -$30.9K
GFL icon
1371
GFL Environmental
GFL
$14.8B
-7,642
Closed -$243K
GH icon
1372
Guardant Health
GH
$22.9B
-29,158
Closed -$864K
GHC icon
1373
Graham Holdings Company
GHC
$4.94B
-671
Closed -$391K
GMED icon
1374
Globus Medical
GMED
$11.7B
-12,145
Closed -$603K
GOGO icon
1375
Gogo Inc
GOGO
$363M
-31,040
Closed -$370K

Similar funds

Joel Greenblatt's Q4 2023 Portfolio in Review

As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
  • Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
  • Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
  • Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
  • Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
  • Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
  • Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.

Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.